Gold Vapor Laser in Photodynamic Therapy for Upper Gastrointesti nal Cancers

Jie LI,Maolin JIN,Boqin YANG,Lin SHEN,Yuqin YANG,Yan LI,Yuezhen TU
DOI: https://doi.org/10.3969/j.issn.1003-9430.2001.01.007
2001-01-01
Abstract:Objective To evaluate the clinical efficacy and adverse effects of gold vapor laser irradiation in photodynamic therapy in patients with advanced c ancers or postoperative local recurrence in the upper gastrointestinal tract. Methods 35 patients with advanced cancers or postoperativ e local recurrence in the upper gastrointestinal tract were treated by photodyna mic therapy with a gold vapor pulsed laser. The wavelength of the red light was 627.8 nm, the power density and energy density used in the treatment were 400- 420 mW/cm2 and 290-300 J/cm2, respectively. Hematoporphyrin derivative (HpD ) was used as photosensitizer, which was given in a dose of 5 mg/kg intravenousl y 12-24 hours before irradiation. The quartz fibre was passed through the biopsy channel of a fiberscope. The treatment was divided into 2-4 segments irradiated for 12 min each according to the size of the lesions. The patients were reexami ned by endoscopy and biopsy 4 weeks after the treatment in order to evaluate the clinical efficacy. Results Evaluation of the 35 patient s included in this group showed that 16 patients (45.7%) had a complete respons e (CR), 7 (20.0%) had a partial response (PR), 7 (20.0%) had a mild response ( MR), while 5 (14.3%) had no response (NR). The total response rate (CR+PR) was 65.7%. There was no significant adverse effect in this group. Conclusions Irradiation with gold vapor pulsed laser is effective an d safe in photodynamic therapy for patients with advanced cancers and postoperat ive recurrence in the upper gastrointestinal tract.
What problem does this paper attempt to address?